Evidence map›Paper›PMID 41604153›Full record

ArticleJAMA network open2026

Health Care-Associated Infections Among Neonates During the COVID-19 Pandemic.

Sagori Mukhopadhyay, Mark Conaway, Miren B Dhudasia, Dustin D Flannery, Michael T Favara, Pablo J Sánchez, Jörn-Hendrik Weitkamp, Sarah Khan, Kristin E D Weimer, Margaret Gilfillan and 12 more

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sagori MukhopadhyayDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Mark ConawayDepartment of Public Health Sciences, University of Virginia, Charlottesville.
Miren B DhudasiaDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Dustin D FlanneryDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Michael T FavaraDepartment of Pediatrics, ChristianaCare, Newark, Delaware.
Pablo J SánchezDepartment of Pediatrics, Division of Neonatology and Pediatric Infectious Diseases, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus.
Jörn-Hendrik WeitkampDepartment of Pediatrics, Vanderbilt University, Nashville, Tennessee.
Sarah KhanDepartment of Pediatrics McMaster University, Hamilton, Ontario, Canada.
Kristin E D WeimerDepartment of Pediatrics, Duke University, Durham, North Carolina.
Margaret GilfillanDepartment of Pediatrics, St Christopher's Hospital for Children, Philadelphia, Pennsylvania.
Andrew BerenzDepartment of Pediatrics, Rush University Medical Center, Chicago, Illinois.
Julie WohrleyDepartment of Pediatrics, Rush University Medical Center, Chicago, Illinois.
Kathryn ZieglerDepartment of Pediatrics, Jefferson University, Philadelphia, Pennsylvania.
Robert L SchelonkaDepartment of Pediatrics, Oregon Health & Science University, Portland.
Redjana CarciumaruDepartment of Pediatrics McMaster University, Hamilton, Ontario, Canada.
Milica IvanovicDepartment of Pediatrics, Oregon Health & Science University, Portland.
Joseph B CanteyDepartment of Pediatrics, University of Texas Health Sciences Center, San Antonio.
Deborah J TuttleDepartment of Pediatrics, ChristianaCare, Newark, Delaware.
Katia C HalabiDepartment of Pediatrics, Division of Neonatology and Pediatric Infectious Diseases, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus.
Ryley GuayDepartment of Pediatrics, Vanderbilt University, Nashville, Tennessee.
Lakshmi SrinivasanDivision of Neonatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
David A KaufmanDepartment of Pediatrics, University of Virginia, Charlottesville.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Neonatal intensive care units (NICUs) implemented enhanced infection prevention measures during the COVID-19 pandemic to interrupt viral transmission. It was hypothesized that these measures would also reduce nonviral health care-associated infections (HAIs). Objective: To compare rates of viral and bacterial or fungal HAIs in infants admitted to the NICU before and during the pandemic. Design, Setting, and Participants: This cohort study was conducted at 12 level 3 or level 4 NICUs in the US and Canada. Participants were inborn and outborn infants admitted from March 1, 2018, to July 31, 2022, for at least 1 overnight stay at participating NICUs. Data analyses were performed from September 1, 2023, to July 28, 2025. Exposure: The viral and bacterial or fungal HAI rates during the pandemic (April 1, 2020, to July 31, 2022) were compared with those before the pandemic (March 1, 2018, to March 31, 2020). Main Outcomes and Measures: HAI incidence before and during the pandemic was expressed as episodes per 1000 patient-days and compared using pre-post and time series analysis with Poisson regression. HAI was defined as an infection diagnosed 3 or more days after admission and was confirmed using molecular diagnostics for viruses and culture of blood, cerebrospinal fluid, or urine for bacteria or fungal pathogens. Results: The full cohort comprised 48 475 infants, grouped into the viral HAI or bacterial or fungal HAI subpopulations. Among 41 889 infants with 966 025 patient-days admitted at 11 NICUs, 231 (mean [SD] gestational age, 30.5 [5.3] weeks; 147 males [63.6%]) had 241 episodes of viral HAI. Viral HAI rates decreased from 0.35 to 0.16 per 1000 patient-days with an adjusted rate ratio (aRR) of 0.45 (95% CI, 0.34-0.59). Reduced rates persisted during the later pandemic period (April 1, 2021, to July 31, 2022) compared with the corresponding period before the pandemic (aRR, 0.58; 95% CI, 0.42-0.80), even as viral infections in the community increased. Among 48 475 infants with 1 130 038 patient-days at 12 study NICUs, 1537 (mean [SD] gestational age, 29.4 [5.2] weeks; 930 males [60.5%]) had 1969 episodes of bacterial or fungal HAI. Bacterial or fungal HAI rates did not decrease from before to during the pandemic (1.70 to 1.78 per 1000 patient-days; aRR, 1.04; 95% CI, 0.95-1.14). At the site level, changes in bacterial or fungal HAI rates did not correlate with viral HAI rates. Conclusions and Relevance: This cohort study found that viral HAIs decreased significantly during the pandemic, while bacterial or fungal HAIs did not. These findings suggest that the enhanced infection prevention measures used during the pandemic may be beneficial during periods of high viral activity but offer limited additional benefit for preventing bacterial or fungal HAI.

Indexed as

Bacterial InfectionsCOVID-19Cross InfectionIntensive Care Units, NeonatalMycosesCanadaCohort StudiesFemaleHumansIncidenceInfant, NewbornMaleSARS-CoV-2United States

Identifiers

PMID41604153
PMCPMC12853212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.